SKBI [SKYSTAR BIO-PHARMACEUTICAL] NT 10-Q: PART II — RULES 12b-25(b) AND (c) [

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: NT 10-Q, Date: 2011-08-16
Original SEC Filing: Click here


Webplus: SKBI/20110816/NT_10-Q/1/000.htm SEC Original: v232252_nt10q.htm
PART II — RULES 12b-25(b) AND (c) [ X ] (a) The reasons described in reasonable detail in Part III of this formuld not be eliminated without unreasonable effort or expense; (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will be filed



Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: NT 10-Q, Date: 2011-08-16CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE

Home Page Forums

By | 2016-02-05T03:34:36+00:00 August 16th, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar